TBPH
Theravance Biopharma Inc
17.00$
+0.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +776.2% | -99.8% | +5,071.7% | +260.4% | +15.5% | -68.4% | +292.4% | +21.6% | -2.1% | -23.0% | -7.2% | +11.8% | +12.1% | +66.9% | |
| – | +2,865.5% | +5.8% | -96.6% | +14.8% | -37.9% | +108.4% | -88.1% | +30,564.1% | +19.0% | -25.8% | -67.3% | -35.9% | -7.3% | -85.3% | |
| – | +46.7% | -845.2% | – | +391.1% | +22.1% | -79.6% | +537.6% | +23.1% | -2.1% | -292.5% | – | – | +59.1% | +281.3% | |
| – | +15.3% | +5.8% | +39.8% | -23.4% | +9.7% | +22.7% | +15.8% | +8.9% | +19.0% | -22.8% | -65.2% | -33.9% | -17.9% | -1.7% | |
| – | – | – | +99.4% | +25.9% | -6.3% | +13.1% | +1.5% | +9.3% | +2.4% | -8.6% | -40.5% | +10.6% | -0.7% | +13.5% | |
| – | +16.1% | +12.0% | +53.5% | -8.7% | +3.1% | +19.1% | +10.7% | +9.0% | +13.6% | -67.7% | -33.1% | -8.9% | +1.2% | +56.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -66.2% | +122.5% | +508.8% | +22.6% | +204.0% | -73.2% | +0.0% | -25.5% | -63.1% | +8.3% | -3.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -85.1% | +963.1% | +35.5% | -177.1% | – | – | – | – | +65,722.2% | +99.3% | +97.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -106.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.